Pages that link to "Q28542081"

The following pages link to Live vaccination tactics: possible approaches for controlling visceral leishmaniasis (Q28542081):

Displaying 18 items.

• Post-Genomics and Vaccine Improvement for Leishmania (Q26752532) (← links)
• Leishmania spp. Proteome Data Sets: A Comprehensive Resource for Vaccine Development to Target Visceral Leishmaniasis (Q26858852) (← links)
• Differences in immune responses against Leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discovery (Q28077110) (← links)
• Vaccination with a Leishmania infantum HSP70-II null mutant confers long-term protective immunity against Leishmania major infection in two mice models (Q33783745) (← links)
• Genetically Engineered Ascorbic acid-deficient Live Mutants of Leishmania donovani induce long lasting Protective Immunity against Visceral Leishmaniasis. (Q35673111) (← links)
• Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis (Q36118527) (← links)
• Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease. (Q38286350) (← links)
• A Non-pathogenic Recombinant Leishmania Expressing Lipophosphoglycan 3 Against Experimental Infection with Leishmania infantum. (Q40244179) (← links)
• Targeted Immunology for Prevention and Cure of VL. (Q41558777) (← links)
• Visceral Leishmaniasis Control and Elimination: Is There a Role for Vaccines in Achieving Regional and Global Goals? (Q47134294) (← links)
• Live Attenuated Leishmania donovani Centrin Gene-Deleted Parasites Induce IL-23-Dependent IL-17-Protective Immune Response against Visceral Leishmaniasis in a Murine Model (Q47349998) (← links)
• Reduced pathogenicity of fructose-1,6-bisphosphatase deficient Leishmania donovani and its use as an attenuated strain to induce protective immunogenicity (Q48514720) (← links)
• New Vaccine Formulations Containing a Modified Version of the Amastigote 2 Antigen and the Non-Virulent Trypanosoma cruzi CL-14 Strain Are Highly Antigenic and Protective against Leishmania infantum Challenge. (Q52723035) (← links)
• Leishmania Hijacks Myeloid Cells for Immune Escape. (Q55043523) (← links)
• Translating Observations From Leishmanization Into Non-Living Vaccines: The Potential of Dendritic Cell-Based Vaccination Strategies Against Leishmania. (Q55282136) (← links)
• Growth arrested live-attenuated Leishmania infantum KHARON1 null mutants display cytokinesis defect and protective immunity in mice (Q58803575) (← links)
• Subcutaneous Immunization of Leishmania HSP70-II Null Mutant Line Reduces the Severity of the Experimental Visceral Leishmaniasis in BALB/c Mice (Q90631842) (← links)
• Mapping Alterations Induced by Long-Term Axenic Cultivation of Leishmania amazonensis Promastigotes With a Multiplatform Metabolomic Fingerprint Approach (Q92190823) (← links)